Talk:Lornoxicam

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Lornoxicam.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Removed text[edit]

The following text was marked as original research and does not seem to be closely related to the article's topic:

Three of the most commonly employed substrate probes for determining CYP2C9 activity in crude human tissue fractions are (S)-warfarin (7-hydroxylation), tolbutamide (methylhydroxylation), and diclofenac (4-hydroxylation). And the best in vivo probes for CYP2C9 activity are tolbutamide and flurbiprofen. Turnover of (S)-warfarin and tolbutamide by CYP2C9 is extremely slow. Conversely, diclofenac has the advantage that CYP2C9 catalyzes its metabolism with a high turnover number, but is not a useful in vivo probe for CYP2C9.

--ἀνυπόδητος (talk) 12:40, 17 December 2010 (UTC)[reply]

This text was part of a WP:NOT PAPERS sounding section ("We suggest lornoxicam as a good Probe for CYP2C9, both In Vitro and In Vivo..."). --ἀνυπόδητος (talk) 13:41, 17 December 2010 (UTC)[reply]